AGEEF - Halo Labs Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2500
+0.0229 (+10.08%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.2271
Open0.2200
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2021 - 0.2550
52 Week Range0.0003 - 0.6800
Volume627,497
Avg. Volume296,600
Market Cap45.934M
Beta (3Y Monthly)-1,706.60
PE Ratio (TTM)N/A
EPS (TTM)-0.1260
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire

    Halo Provides Update on Bophelo Biosciences Signing and Closing

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide an update to a previous press release on September 4th that the Company anticipates signing definitive documents with Bophelo Biosciences Ltd. (“Bophelo”) in Lesotho, Africa within the next two to three weeks. “The planned acquisition of Bophelo is a very important milestone for Halo. Bophelo’s initial 5-hectare site is almost two times the size of the Evans Creek site in Southern Oregon, and Bophelo’s conditional approval of up to 200 hectares of outdoor grow would be one of largest cannabis cultivation projects worldwide that we know of,” said Kiran Sidhu, CEO and Co-Founder of Halo Labs.

  • Business Wire

    Halo Labs Announces Debt Financing of up to C$10 Million

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced that it has entered into an unsecured debt financing agreement (the “Agreement”) with a private arm’s-length lender (the “Lender”) for a principal amount of up to C$10,000,000. The Agreement is for an initial twelve month term (the “Initial Term”) with interest accruing at a rate of 9%. The Company has the ability to extend the Initial Term for an additional 12 months at an interest rate of 13% following the Initial Term.

  • Business Wire

    Halo Signs Bulk Extract Supply Agreement With Caliva

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into a bulk supply agreement (the “Agreement”) with NC3 Systems (“Caliva”) to provide bulk distillate, bulk live resin and live resin packaged as finished products. Timing and frequency of orders is at the discretion of Caliva. Caliva is the leader in California’s cannabis industry, holding 14 total cannabis licenses, placing products in more than 200 stores state wide and servicing roughly 700,000 total customers throughout the Golden State.

  • Business Wire

    Halo 80 Cent Warrants to Commence Trading on the NEO

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the warrants issued in connection with Halo’s private placement which closed on June 29, 2018 and business combination which closed on October 2, 2018 (the “Warrants”) have been approved for listing on the NEO Exchange. The Warrants are expected to commence trading on or about September 11, 2019 under the symbol HLO.WT.A. “We are pleased that the Warrants have been approved for listing on the NEO Exchange as this will provide additional liquidity for our stakeholders,” said Kiran Sidhu, CEO and Co-Founder.

  • Business Wire

    REPEAT/Halo Announces Update on Bophelo Biosciences

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide an operational update given recent developments at Bophelo Biosciences Ltd. (“Bophelo”) in Lesotho, Africa. Halo’s CEO and Co-Founder, Kiran Sidhu, commented: “I am happy to provide our investors with further insight and updates surrounding our international operations. Halo and Bophelo are in the process of negotiating mutually agreeable definitive agreements and the parties expect to sign such definitive agreements within the next thirty days.

  • Business Wire

    Halo Announces Update on Bophelo Biosciences

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide an operational update given recent developments at Bophelo Biosciences Ltd. (“Bophelo”) in Lesotho, Africa. Halo’s CEO and Co-Founder, Kiran Sidhu, commented: “I am happy to provide our investors with further insight and updates surrounding our international operations. Halo and Bophelo are in the process of negotiating mutually agreeable definitive agreements and the parties expect to sign such definitive agreements within the next thirty days.

  • Halo Announces Proposed Purchase of 17.5% of Ukiah Ventures, a California Cannabis Conglomerate
    Business Wire

    Halo Announces Proposed Purchase of 17.5% of Ukiah Ventures, a California Cannabis Conglomerate

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce it has entered into a letter of intent with respect to the proposed investment by Halo of 1,333,333 common shares of Ukiah Ventures Inc. (“UVI”) (which will equal an approximate 17.5% ownership interest) in exchange for 5,940,000 common shares of Halo (the “Transaction”). UVI is a cannabis distribution, processing and manufacturing company providing biomass procurement and value-added services such as drying, trimming, packaging, freezing and storing cannabis. Based in Ukiah, California, UVI is led by a group of seasoned cannabis entrepreneurs who operate a 30,000 square foot processing and manufacturing facility located adjacent to California’s highway 101 allowing for logistical advantages to service the entire of California.

  • Business Wire

    REPEAT/Halo Labs Awarded Two Permanent Licenses at Second California Facility

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has been awarded two permanent California state licenses: a Type 11 Distribution and a Type 7 Volatile Manufacturing, for the company’s second facility in Cathedral City (“ICL 9”). As previously disclosed, ICL 9 also has Cathedral City local cannabis business licenses for both manufacturing and distribution.

  • Business Wire

    Halo Labs Awarded Two Permanent Licenses at Second California Facility

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has been awarded two permanent California state licenses: a Type 11 Distribution and a Type 7 Volatile Manufacturing, for the company’s second facility in Cathedral City (“ICL 9”). As previously disclosed, ICL 9 also has Cathedral City local cannabis business licenses for both manufacturing and distribution.

  • Benzinga

    Halo Labs Partners With ilo Vapor To Launch New Wellness Brand

    Cannabis extraction company Halo Labs Inc. (NEO: HALO) (OTCQX: AGEEF) announced Monday its partnership with ilo Vapor to launch Levätä, a special wellness brand that will rely on DabTabs technology to develop a unique measured dose cannabinoid consumption solution. Levätä CBD dosables will allow consumers to measure their CBD consumption with high accuracy providing also a vape pen styled device created by ilo, the company said. “Consumers of cannabinoid products are becoming increasingly passionate about the wellness benefits of CBD,” said Michael Lindars, CEO and Co-Founder of ilo.

  • REPEAT/Halo Announces Partnership with ilo to Sell CBD Products Utilizing DabTabs™ Technology
    Business Wire

    REPEAT/Halo Announces Partnership with ilo to Sell CBD Products Utilizing DabTabs™ Technology

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce a collaboration with ilo Vapor™ (“ilo”) to launch Levätä™, an alternative wellness brand focused on utilizing DabTabs™ technology to create a unique measured dose cannabinoid (“CBD”) consumption solution. To compliment the experience, the Levätä™ collection will also include a vape pen styled device custom made for DabTabs™ dosables, which utilizes the DabTabs™ Go technology developed by ilo. Halo expects to begin sales of the Levätä™ collection to retailers in October, leveraging its direct sales force in California, Oregon, and Nevada.

  • Halo Announces Partnership with ilo to Sell CBD Products Utilizing DabTabs™ Technology
    Business Wire

    Halo Announces Partnership with ilo to Sell CBD Products Utilizing DabTabs™ Technology

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce a collaboration with ilo Vapor™ (“ilo”) to launch Levätä™, an alternative wellness brand focused on utilizing DabTabs™ technology to create a unique measured dose cannabinoid (“CBD”) consumption solution. To compliment the experience, the Levätä™ collection will also include a vape pen styled device custom made for DabTabs™ dosables, which utilizes the DabTabs™ Go technology developed by ilo. Halo expects to begin sales of the Levätä™ collection to retailers in October, leveraging its direct sales force in California, Oregon, and Nevada.

  • Business Wire

    Halo Labs Reports Q2 2019 Financial Results

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced its financial and operational results for the second quarter for the period ended June 30, 2019 (“Q2”). The California market continues to be a significant growth factor for Halo as revenues in Q2 totaled $9,552,012 representing a 356% increase over Q2 2018 (three-month period ended June 30, 2018: $2,093,468) and a 10% increase quarter over quarter in comparison to Q1 2019 (three-month period ended to March 31, 2019: $8,718,503).

  • Halo Announces Partnership with Nabis Provides Distribution Across Entire State of California
    Business Wire

    Halo Announces Partnership with Nabis Provides Distribution Across Entire State of California

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into a distribution agreement (the “Agreement”) with one of California’s largest full service distributors, Nabis, to supply California dispensaries with Halo’s full assortment of branded products. This agreement provides Halo with distribution coverage across the entire state of California. Nabis currently distributes over 60 brands to more than 650 dispensaries throughout California while providing an intuitive online platform that brings simplicity and efficiency to the cannabis supply chain.

  • REPEAT/Halo Announces the Launch of XES Sensual, a Unique CBD Sexual Wellness Product Continues Company Trend of Product Innovation in Growing Category
    Business Wire

    REPEAT/Halo Announces the Launch of XES Sensual, a Unique CBD Sexual Wellness Product Continues Company Trend of Product Innovation in Growing Category

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it is launching XES Sensual, the first sexual wellness system with an integrated applicator, specifically designed to deliver a cannabidiol (“CBD”) formulation through vaginal application. XES Sensual is the first sexual wellness product that features both an applicator and serum and applies cannabinoid science to promote sexual pleasure. According to a report published in April 2019 by Arizton Advisory & Intelligence, the global sexual wellness market is expected to reach revenues of around $39 billion by 2024, growing at a CAGR of over 7% during 2018 − 2024.

  • Halo Announces the Launch of XES Sensual, a Unique CBD Sexual Wellness Product Continues Company Trend of Product Innovation in Growing Category
    Business Wire

    Halo Announces the Launch of XES Sensual, a Unique CBD Sexual Wellness Product Continues Company Trend of Product Innovation in Growing Category

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it is launching XES Sensual, the first sexual wellness system with an integrated applicator, specifically designed to deliver a cannabidiol (“CBD”) formulation through vaginal application. XES Sensual is the first sexual wellness product that features both an applicator and serum and applies cannabinoid science to promote sexual pleasure. According to a report published in April 2019 by Arizton Advisory & Intelligence, the global sexual wellness market is expected to reach revenues of around $39 billion by 2024, growing at a CAGR of over 7% during 2018 − 2024.

  • Benzinga

    Halo Labs To List On OTC Market Cannabis Index

    Cannabis extraction company Halo Labs Inc. (OTC: AGEEF ) (NEO: HALO) announced Thursday  that its stock is joining the OTC Market Cannabis Index under the ticker symbol ".OTCQXMJ." Halo Labs ...

  • Newsfile

    Taking a Page from the Canopy Growth Playbook, Halo Invests in Lesotho Cannabis -- CFN Media

    Seattle, Washington--(Newsfile Corp. - July 12, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Halo Labs (OTCQX: AGEEF) (NEO: HALO) (FSE: A9KN) strategic move into Lesotho, South Africa.Lesotho (pronounced "le-so-toe" or "le-sue-two") is a landlocked kingdom surrounded by South Africa. Most people probably never heard of it until recently, as in 2017 it was the ...

  • OTC Markets Group Announces Quarterly Index Performance and Rebalancing
    PR Newswire

    OTC Markets Group Announces Quarterly Index Performance and Rebalancing

    NEW YORK , July 11, 2019 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the second quarter 2019 performance ...

  • Business Wire

    REPEAT/Ms. Louisa Mojela to Speak on Social Justice and Environmental Sustainability at Parliament of the United Kingdom on June 24, 2019

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Ms. Louisa Mojela, proposed chairman of Halo and founder and executive chair of Women Investment Portfolio Holdings, will speak on a panel at the European Global Cannabis Partnership launch at the House of Commons on Monday June 24th from 18:40-20:15. Ms. Mojela is a panelist on the Social Justice and Environmental Sustainability panel that will explore the newly-developing European cannabis industry and the unique opportunity to serve as a model for social and environmental sustainability.

  • Business Wire

    Ms. Louisa Mojela to Speak on Social Justice and Environmental Sustainability at Parliament of the United Kingdom on June 24, 2019

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Ms. Louisa Mojela, proposed chairman of Halo and founder and executive chair of Women Investment Portfolio Holdings, will speak on a panel at the European Global Cannabis Partnership launch at the House of Commons on Monday June 24th from 18:40-20:15. Ms. Mojela is a panelist on the Social Justice and Environmental Sustainability panel that will explore the newly-developing European cannabis industry and the unique opportunity to serve as a model for social and environmental sustainability.

  • Business Wire

    REPEAT/Lesotho Deputy Prime Minister, Mr. Monyane Moleleki, to Join Halo and Ms. Mojela at European Cannabis Week

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Deputy Prime Minister of Lesotho, Mr. Monyane Moleleki will be joining CEO of Halo Labs Kiran Sidhu and Chairman of Bophelo Bioscience Ms. Louisa Mojela at Prohibition Partners Cannabis Europa, IMN’s Inaugural Institutional Capital & Cannabis Conference in Europe (IC3), and other events throughout the week of June 24th 2019.